Gene therapy for cerebral vascular disease: update 2003.
about
Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain.Drug delivery systems for the treatment of ischemic stroke.Protein therapy using heme-oxygenase-1 fused to a polyarginine transduction domain attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.Cerebrovascular involvement in liposome-induced cardiopulmonary distress in pigs.Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.
P2860
Gene therapy for cerebral vascular disease: update 2003.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy for cerebral vascular disease: update 2003.
@en
type
label
Gene therapy for cerebral vascular disease: update 2003.
@en
prefLabel
Gene therapy for cerebral vascular disease: update 2003.
@en
P2093
P2860
P356
P1476
Gene therapy for cerebral vascular disease: update 2003.
@en
P2093
Donald D Heistad
Kazunori Toyoda
P2860
P356
10.1038/SJ.BJP.0705217
P407
P577
2003-05-01T00:00:00Z